Flavonoids and Other Polyphenols Act as Epigenetic Modifiers in Breast Cancer

Priyanga Selvakumar1, Aja Badgeley1, Paige Murphy1

  • 1Department of Pharmaceutical Sciences, Jefferson College of Pharmacy, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Nutrients
|March 19, 2020
PubMed

Insights

Flavonoids, plant compounds, show anti-cancer effects against breast cancer. Key factors like subtype, menopausal status, and dosage (around 10 mg/day isoflavones) influence their effectiveness, potentially through epigenetic modifications.

Area of Science:

  • Oncology
  • Nutritional Science
  • Epigenetics

Background:

  • Breast cancer arises from genetic mutations and epigenetic alterations.
  • Epidemiological studies suggest an inverse relationship between flavonoid consumption and breast cancer incidence.
  • Flavonoids, plant-derived polyphenolic compounds, are researched for their anti-cancer properties.

Purpose of the Study:

  • To review the anti-cancer activity of flavonoids against breast cancer.
  • To identify factors influencing flavonoid efficacy in breast cancer.
  • To explore the epigenetic mechanisms of flavonoid action in breast cancer.

Main Methods:

  • Review of existing epidemiological and experimental studies on flavonoids and breast cancer.
  • Analysis of factors such as breast cancer subtype, menopausal status, and dosage.
  • Examination of flavonoid-induced epigenetic modifications, including DNA methylation and chromatin remodeling.

Main Results:

  • Flavonoids demonstrate anti-cancer activity across diverse ethnic populations with breast cancer.
  • Breast cancer subtype and menopausal status significantly modulate flavonoid anti-cancer effects.
  • An intake of approximately 10 mg/day of isoflavones may inhibit breast cancer occurrence.
  • Specific flavonoids (epigallocatechin, genistein, resveratrol) inhibit DNA methyltransferase and alter chromatin modification.
  • Flavonoids can upregulate tumor suppressor genes, potentially reducing breast cancer progression and metastasis.

Conclusions:

  • Flavonoids possess significant anti-cancer potential against breast cancer, influenced by host and compound-specific factors.
  • Epigenetic modulation, including DNA methylation and chromatin changes, is a key mechanism underlying flavonoid anti-cancer activity.
  • Further research is warranted to confirm the role of flavonoid-induced epigenetic modifications in breast cancer prevention.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.5K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.6K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K